Why

Continued and compelling need for affordable therapies globally

Absence of a robust drug discovery and development pipeline of affordable and accessible therapeutics.

Failure of the pharmaceutical industry to develop and deliver drugs to ~90% of global patient population.

Pharmaceutical industry's drug discovery and development decisions purely based on financial return not on patient impact.

With over 9000 identified diseases at the current rate of development and cost, the pharmaceutical industry CANNOT provide the solution patients and society need.

Underinvestment in women's health, rare diseases, and pediatric indications mean these patients have fewer, if any, choices to manage their disease. Our platform will allow us to have far-reaching impact with rapid results.